Big Pharma Drug Trials Critically Injure Six, Leaving One Brain Dead; Mainstream Media Points Finger at Marijuana NOT Used in Experiment
by Julie Wilson, Natural News:
A Portugal-based drug maker is being accused of trying to conceal details about a clinical drug trial that went severely awry earlier this month, leaving one person brain-dead and four others seriously injured. The trial took place in Rennes, France, and was conducted by Biotrial, a third-party drug evaluation and pharmacology research firm with offices in London and Newark, New Jersey.
The drug being tested was a painkiller manufactured by Bial, one of the largest and oldest pharma companies in Portugal that was founded nearly a century ago. Following the botched trial, the drug maker has been accused of taking a “secretive stance” and muddying the waters, making it difficult for outside researchers to understand what went wrong.
“The first reports on the Rennes tragedy were understandably confused. Adding to the shock of the tragedy, the secretive stance taken by the drug manufacturer made things even murkier,” said Dr. Daniele Piomelli, Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy & Neurobiology at the University of California, Irvine School of Medicine, told Outsourcing-Pharma.com.
Scientists demand transparency
“One person died and several were hurt. This is a tragedy and we cannot turn away from it,” Dr. Piomelli added. “As a scientist active in the field, I feel an obligation to understand what went wrong. And to demand transparency from the drug manufacturer.”
Early reports claimed that the experimental painkiller may have contained or was derived from cannabis. But that theory was quickly debunked when researchers clarified that the drug was a long-action inhibitor of FAAH (Fatty Acid Amide Hydrolase). Reports that the painkiller was somehow related to marijuana originated from an unidentified source who claimed to be close to the case.
The confusion may have stemmed from the fact that the drug being tested “targeted the body’s pain-controlling endocannabinoid system, which is also responsible for the human response to cannabis,” according to.
Ninety individuals received the experimental painkiller, while 30 others were given a placebo. Six of the volunteers aged 28 to 49 were taken to the hospital, including the brain-dead man, said French Health Minister Marisol Tourain, who called it “an accident of exceptional gravity.”(3)
